Related Experiment Video
Updated: May 11, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
An anxious heart: anxiety and the onset of cardiovascular diseases
Rebecca C Thurston1, Marissa Rewak, Laura D Kubzansky
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA. thurstonrc@upmc.edu
Insights
Anxiety is a significant modifiable risk factor for cardiovascular disease (CVD). Addressing anxiety may offer a key strategy for preventing CVD and reducing its public health burden.
Area of Science:
- Public Health
- Cardiology
- Psychiatry
Background:
- Cardiovascular disease (CVD) poses a substantial public health burden.
- Modifiable risk factors for CVD include health behaviors, risk factors, and mental health conditions like anxiety.
- Anxiety is increasingly recognized as a potentially modifiable CVD risk factor.
Purpose of the Study:
- To examine the role of anxiety in the development of cardiovascular disease (CVD).
- To evaluate anxiety as a target for primordial CVD prevention strategies.
- To summarize current research on anxiety and incident CVD and subclinical CVD outcomes.
Main Methods:
- Literature review and synthesis of existing research findings.
- Analysis of studies investigating the link between anxiety and CVD incidence.
- Exploration of potential mechanisms linking anxiety to CVD.
Main Results:
- Anxiety is associated with an increased risk of developing cardiovascular disease (CVD).
- Evidence suggests anxiety impacts both clinical and subclinical CVD outcomes.
- Several potential biological and behavioral mechanisms may mediate the anxiety-CVD relationship.
Conclusions:
- Anxiety represents a critical, modifiable target for cardiovascular disease (CVD) prevention.
- Primordial prevention strategies should consider addressing anxiety to mitigate CVD risk.
- Clinical providers should be aware of the link between anxiety and CVD and incorporate relevant assessments and interventions.
Abstract:
The public health burden of cardiovascular disease (CVD) is high both in terms of economic and social costs. Key modifiable factors identified for CVD prevention include health behaviors and health risk factors (e.g., cholesterol, blood pressure). However, a substantial body of research has also identified stress, anxiety, and depression as potentially modifiable CVD risk factors. Here we focus on the role of anxiety in the development of CVD and consider its potential as a key target for primordial prevention strategies. First, we highlight important findings and summarize the latest research on anxiety and incident CVD. We also review and summarize the findings to date on subclinical CVD outcomes and briefly consider mechanisms by which anxiety may influence CVD. We identify key issues and consider how these issues may inform our understanding of the anxiety-CVD relationship. Finally, we briefly discuss the clinical implications of this work, with specific recommendations for providers.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...